Syphilis clinical trials at University of California Health
2 in progress, 1 open to eligible people
Modernizing Perinatal Syphilis Testing
open to eligible people ages up to 45 years
Treponema pallidum is a bacterium that causes the disease syphilis. The primary objective of the study is to evaluate the testing performance of two diagnostic molecular techniques [quantitative polymerase chain reaction (qPCR) and transcription-mediated amplification (TMA)] for the detection of Treponema pallidum in maternal and neonatal specimens from participants with the diagnosis of syphilis using the Centers for Disease Control's (CDC's) Sexually Transmitted Infections (STI) Treatment Guidelines for adult and congenital syphilis.
at UCLA
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Sorry, currently not accepting new patients, but might later
The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.
at UCLA
Our lead scientists for Syphilis research studies include Cherie Blaire, MD, PhD.
Last updated: